TrialClinical pharmacokinetics2026

Vutrisiran-Mediated Knockdown of Transthyretin in Patients with ATTR Amyloidosis.

Marianna Fontana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.